RISW2025
Back to all people

Lan Luo

Merck & Co., Inc.
2 appearances in the program

Sessions & presentations

PS30: Statistical Consideration of Concentration-QTc Modeling in Oncology
Parallel · Fri, Sep 26 , 8:30 AM
Co-Organizer
PS30: Statistical Consideration of Concentration-QTc Modeling in Oncology
Presentation: Enabling Robust Concentration-QTc Assessment for Early Oncology Clinical Trials
Parallel · Fri, Sep 26 , 8:30 AM
Presenting Author
↑